High-intensity focused ultrasound therapy proved to be a highly-effective cancer treatment in various studies and clinical trials.
For instance, researchers at the University College Hospital in London examined 625 men with prostate cancer and found that 93 percent of patients who underwent HIFU alone remained cancer-free at five years following the treatment, without requiring surgery or radiotherapy. Data also showed that only one to two percent of patients who had HIFU treatment suffered long-term urinary incontinence, compared with 10 to 20 percent of patients who had surgery. In addition, only 15 percent of patients in the HIFU group developed erectile dysfunction compared with 30 to 60 percent of surgical patients.
“The results of this study are impressive and have the potential to transform prostate cancer treatment for many men in the future. It is extremely exciting technology and these results show that in men diagnosed early by prostate-specific antigen (PSA) blood testing, this targeted therapy could be as effective as surgery to remove the whole prostate gland or radiotherapy and cause far fewer side effects,” said study co-author Tim Dudderidge.
The findings were presented at an annual meeting of the European Association of Urology in Munich, Germany.